Bleeding Disorders
From the Journals
Family history plays a large role in bleeding disorder diagnosis in women
The survey of women with congenital bleeding disorders in Europe highlighted delays in diagnosis and burdens on activities of daily living.
News
Peanut contamination risk prompts Promacta recall
Three lots were affected by potential peanut flour contamination at a third-party manufacturing site.
Conference Coverage
QOL concerns prompt second-line therapy in children with ITP
NEW ORLEANS – Quality of life was the most common reason for starting second-line therapy in a cohort of children with immune thrombocytopenia.
From the Journals
Study finds lower quality of life for patients with hemophilia A
Patients with hemophilia A reported lower health-related quality of life even though they were receiving standard treatment.
From the Journals
New recommendations on immune tolerance induction in hemophilia A
A nine-member expert panel recommended the concurrent use of factor VIII replacement therapy and emicizumab to inhibit bleeding with lower-dose...
From the Journals
Study identifies GI bleed risk factors in von Willebrand disease
The most significant cause of GI bleeding in patients with von Willebrand disease was angiodysplasia.
Conference Coverage
LentiGlobin reduces transfusion dependence in young thalassemia patients
NEW ORLEANS – Children and young adults with non-beta0/beta0 thalassemia achieved transfusion independence in two trials.
Conference Coverage
TTP death linked to elevated troponin and neurological signs
GLASGOW – The registry-based study showed that more than 70% of patients who presented with thrombotic thrombocytopenic purpura had neurological...
From the Journals
Extended half-life clotting factors cut infusions, hike prices
The use of extended half-life clotting factors was able to significantly reduce the number of infusions but the cost went up significantly.
From the Journals
HAVEN 4: Monthly emicizumab shows value
Emicizumab was effective as a monthly treatment for patients with hemophilia A, both with and without inhibitors, according to an ongoing phase 3...
From the Journals
New consensus recommendations on vaccination in hemophilia
Vaccination in patients with hemophilia should be provided on the same institutional schedule but planning should take into account disease-...